Integra LifeSciences Cor... (IART)
NASDAQ: IART
· Real-Time Price · USD
14.80
0.83 (5.94%)
At close: Oct 03, 2025, 3:59 PM
14.80
0.00%
After-hours: Oct 03, 2025, 07:58 PM EDT
5.94% (1D)
Bid | 10.52 |
Market Cap | 1.15B |
Revenue (ttm) | 1.62B |
Net Income (ttm) | -500.63M |
EPS (ttm) | -6.54 |
PE Ratio (ttm) | -2.26 |
Forward PE | 5.77 |
Analyst | Hold |
Dividends | n/a |
Ask | 18.17 |
Volume | 1,045,928 |
Avg. Volume (20D) | 1,236,180 |
Open | 14.18 |
Previous Close | 13.97 |
Day's Range | 13.98 - 14.87 |
52-Week Range | 11.06 - 27.13 |
Beta | 1.21 |
Ex-Dividend Date | n/a |
About IART
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IART
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IART stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsIntegra LifeSciences Corporation is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+6.22%
Integra LifeSciences shares are trading higher aft...
Unlock content with
Pro Subscription
5 months ago
-21.19%
Integra LifeSciences shares are trading lower after the company reported a Q1 adjusted EPS miss, issued Q2 guidance below estimates, and cut its FY25 adjusted EPS guidance.

2 months ago · seekingalpha.com
Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call TranscriptIntegra LifeSciences Holdings Corporation (NASDAQ:IART ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Executives Christopher Ward – Senior Director of Investor Relations Lea Daniels Knigh...

2 months ago · fool.com
Integra (IART) Q2 Revenue Beats by 5%Integra (IART) Q2 Revenue Beats by 5%